28 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
and antitrust regulations, the United States Foreign Corrupt Practices Act, or the FCPA, quality assurance and other healthcare regulatory requirements
8-K
EX-14.1
h7s21n3wb
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.25
ab36lj0
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.23
tbglt nwgqskez04e
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.24
c36umbpq9jrl
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.26
v86bgwwnm gn
27 Jul 23
Index to Financial Statements
5:28pm
425
EX-10.4
s00oqoh0w m4
29 Jun 23
Business combination disclosure
9:20pm
425
EX-10.5
v15molus
29 Jun 23
Business combination disclosure
9:20pm
8-K
EX-10.4
aewda5bu9of1 orl57
29 Jun 23
Entry into a Material Definitive Agreement
9:18pm
8-K
EX-10.5
nxgxfurn5 5lvi
29 Jun 23
Entry into a Material Definitive Agreement
9:18pm
DEFM14A
ubz8g7zzgzhrnrl6
12 May 23
Proxy related to merger
5:00pm
424B3
zk4hylds u0uqnmy
12 May 23
Prospectus supplement
4:33pm